Ryman Healthcare

New Leadership And Pricing Reforms Will Boost Aged Care

AnalystConsensusTarget

Not Invested

Based on Analyst Price Targets

Published

22 Apr 25

Updated

01 May 25

AnalystConsensusTarget's Fair Value

NZ$2.83

4.4% undervalued

04 Sep

NZ$2.70

-41.8%

8.9%

-41.8%

8.9%

You can edit this narrative until May 12 6:00 AM. Then, changes will post as Updates.

Author's Valuation

NZ$2.834.4% undervalued

AnalystConsensusTarget Fair Value

Narrative

Updates1

Shared on01 May 25
Fair value Decreased 2.59%

AnalystConsensusTarget Fair Value

NZ$2.83

4.4% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

7.10%

Healthcare Services revenue growth rate

0.24%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

7.00%

Calculation

NZ$390.01m

Earnings '28

11.00x

PE Ratio '28

NZ$4.29b

Market Cap '28

NZ$4.29b

Market Cap '28

1.24b

No. shares '28

NZ$3.45

Share Price '28

NZ$3.45 Share Price '28

Discounted to 2025 @ 6.92% p.a.

NZ$2.82

Fair Value '25

New Leadership And Pricing Reforms Will Boost Aged Care

Shared on01 May 25Fair value Decreased 2.59%

Shared on01 May 25
Fair value Decreased 2.59%